Trial NCT04691375

View at ClinicalTrials.gov 
Org. Study IDs: PY314-1-01

Last trial update was posted on 2024-03-22

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma of Lung Breast Neoplasms Carcinoma, Renal Cell Triple Negative Breast Neoplasms

Other Conditions

Advanced Solid Tumor Breast Cancer Colorectal Cancer Gynecologic Cancer Hormone Receptor/Growth Factor Receptor-Negative Breast Cancer Lung Adenocarcinoma Ovarian Cancer Renal Cell Carcinoma Triple Negative Breast Cancer

Stopping Reasons

Sponsor business decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID